Eli Lilly and Company · 13 hours ago
Indirect Tax Analyst
Eli Lilly and Company is a global healthcare leader headquartered in Indianapolis, Indiana. The Indirect Tax Analyst position is primarily responsible for all aspects of indirect tax compliance, audits, and forecasting, supporting U.S. sales tax compliance and property tax compliance.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Prepare filings and analysis for indirect tax compliance and forecasting
Develop training materials and present indirect tax training to internal business partners
Function as an internal subject matter expert for property taxes
Coordinate and collect data for property and sales/use tax audits
Support sales/use tax outsourced compliance
Provide indirect tax support, including accounting, tax engine knowledge, and special projects
Qualification
Required
Bachelor's Degree, preferably in Accounting or Finance
3+ years of corporate indirect tax experience, including property tax experience
Microsoft Office proficiency
Strong business partner skills
Demonstrated ability to prioritize and meet deadlines
Qualified applicants must be authorized to work in the United States on a full-time basis. Lilly will not provide support for or sponsor work authorization and/or visas for this role
Preferred
Working knowledge of SAP
Indirect tax audit experience
Vertex or similar sales/use tax engine experience
Multi-state property tax experience
Federal and/or state corporate income tax compliance experience
Benefits
Company bonus
Company-sponsored 401(k)
Pension
Vacation benefits
Eligibility for medical, dental, vision and prescription drug benefits
Flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
Life insurance and death benefits
Certain time off and leave of absence benefits
Well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Company
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world.
Funding
Current Stage
Public CompanyTotal Funding
$6.5M2024-02-12Post Ipo Debt· $6.5M
1978-01-13IPO
Leadership Team
Recent News
Company data provided by crunchbase